ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FAB Fusion Antibodies Plc

3.275
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.275 3.25 3.30 3.275 3.275 3.28 141,876 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0437 -0.75 1.94M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.28p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 50.00p.

Fusion Antibodies currently has 59,453,714 shares in issue. The market capitalisation of Fusion Antibodies is £1.94 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -0.75.

Fusion Antibodies Share Discussion Threads

Showing 3951 to 3973 of 4075 messages
Chat Pages: 163  162  161  160  159  158  157  156  155  154  153  152  Older
DateSubjectAuthorDiscuss
23/1/2024
08:09
That cash position is the great uncertainty, hopefully resolved very shortly so means now is the great opportunity. The NCI collaboration should certainly have put us on the radar well
cbeadle
23/1/2024
07:47
I think you need to listen to the presentation whereby they are reaching a cash neutral position monthly To me anything in the 4 or 5 is going to allow you to double your money soon
bigjock36
23/1/2024
06:10
Don't think I would be topping up yet . Cash position is perilous and suspect another placing coming very soon at a discount say 3p . Might aswell wait until after that is done and get them cheaper if you believe the company will turn things around .
Cost cutting etc is good but left it late and turnover needs to increase next results or any faith will be gone . I've seen worse that's for sure but like most they need cash and that's a problem in these markets .

bones698
22/1/2024
17:39
Looks like some people did exactly that below 5.5p cbeadle. Time will tell whether they were smart or not.
cyberbub
22/1/2024
14:49
If I had any spare cash I would top up now
cbeadle
22/1/2024
14:22
Just another sad troll cyber
walter walcarpets
22/1/2024
13:39
Blackhorse has been pumping APH across multiple boards for months, here and on LSE, lol. "Good returns", APH has been flat or falling for almost that entire time! LOL.
cyberbub
22/1/2024
13:26
Glad switched to APH from here , giving me good returns
blackhorse23
19/1/2024
17:26
Not seeing much to get excited about here yet . No news or new deals announced yet and coat cuttings and cost savings to try and preserve cash shows how precarious the current cash position is . Low mkt cap though but need to see signs of deals coming after a poor H2 which saw revenues decline by some margin ..traders causing a bit of a spike
bones698
19/1/2024
12:00
Sold my trading ones at 7.75p and now back in again for the next big move up.
I always keep my main holding intact.

luckyabbeygale
19/1/2024
11:50
Out with profit & going to buy APH ( https://www.alliancepharmaceuticals.com )
blackhorse23
19/1/2024
10:23
8.5p lowest ask now showing 8.5p.

f

fillipe
19/1/2024
10:06
Breakout! :-)
lawson27
19/1/2024
09:32
Lowest ASK on show, currently 7.5p and that been paid.

f

fillipe
19/1/2024
08:31
Looks like a more sustainable re-rate this time.
walter walcarpets
19/1/2024
08:29
Good start, FAB would totally explode if there is a transformational RNS.
cbeadle
18/1/2024
12:00
Agreed, it's easy to see a run into double digits soon...
cyberbub
18/1/2024
11:53
Any chartists here should think we are approaching the golden cross and break out soon !//
bobaxe1
18/1/2024
08:36
Having done my research, the company seems to have a lot going for it, the market cap is ludicrously low for what it has, especially with the NCI collaboration which should generate good news flow throughout 2024. As always with AIM, shorters and spivs have hammered the cap down whenever the company needed cash, to the current crazy valuation. It would definitely be at the very least 10x the current cap if listed in the US today. But we are where we are. There are still justifiable concerns over their cash level, but the company is taking firm action to reduce outflows, and it seems that revs are starting to pick up. If it seems clear in the next couple of months that they can get away without another spivs' front-run placing, then the share price should rocket IMHO. Maybe even a director loan or a small £250-500k private placing, are options to see them through? Good luck all.
cyberbub
18/1/2024
08:02
The CFO on the Investor Meets Company presentation did indeed say that cash was flat from September to October and that they had already paid out the redundancy payments from the downsizing.
cyberbub
17/1/2024
16:11
Real spread for 100k shares is 5.45 - 5.85 at this point.
cyberbub
17/1/2024
15:54
Looks like 🚀 🚀 🚀 about to blast 💥 off here, get on board folks!
cbeadle
17/1/2024
15:33
Paying full offer now....
cyberbub
Chat Pages: 163  162  161  160  159  158  157  156  155  154  153  152  Older

Your Recent History

Delayed Upgrade Clock